Live from the NIH registry
Studies recruiting near Gainesville right now
Top 25 of 149 recruiting studies, sorted by proximity — each links to its official registry page
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Northeast Georgia Medical Center-Gainesville — Gainesville, Georgia (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Georgia Nephrology — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Cleaver Medical Group Dermatology — Cumming, Georgia (18.7 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Ambros Therapeutics, Inc.
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
ProCare Prosthetics x Ottobock.care — Buford, Georgia (15.4 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients
Foot Injuries and Disorders, Ankle Injuries and Disorders
Phase 2
Interventional 180 participants sought
Emory Sports Medicine Complex and Emory Orthopaedics and Spine Center — Johns Creek, Georgia (27.8 mi)
· Sponsor: Emory University
Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) Intraocular Lens (IOL) in Adult Participants for Correction of Aphakia Following Cataract Extraction
Aphakia, Postcataract
N/A
Interventional 340 participants sought
North Georgia Eye Associates — Gainesville, Georgia (0.6 mi)
· Sponsor: Kowa Research Institute, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Northeast Georgia Medical Center-Gainesville — Gainesville, Georgia (0.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Iron Deficiency Anemia
Phase 3
Interventional 75 participants sought
Gwinnett Research Institute — Buford, Georgia (15.4 mi)
· Sponsor: AMAG Pharmaceuticals, Inc.
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
NSC Research Inc — Johns Creek, Georgia (27.8 mi)
· Sponsor: Boehringer Ingelheim
Assessment of CCM in HF With Higher Ejection Fraction
Heart Failure, Heart Failure With Preserved Ejection Fraction
N/A
Interventional 1,500 participants sought
Northeast Georgia Health System — Gainesville, Georgia (0.6 mi)
· Sponsor: Impulse Dynamics
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Physicians Research Associates LLC — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Zucara Therapeutics Inc.
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
Center for Advanced Research & Education — Gainesville, Georgia (0.6 mi)
· Sponsor: Hoffmann-La Roche
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Northeast Georgia Medical Ctr — Gainesville, Georgia (0.6 mi)
· Sponsor: Novo Nordisk A/S
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
One Health Research Clinic Inc. — Johns Creek, Georgia (27.8 mi)
· Sponsor: pH-D Feminine Health LLC
Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
Localized Colon Carcinoma, Stage IIB Colon Cancer AJCC v8
Phase 2
Interventional 40 participants sought
Emory Johns Creek Hospital — Johns Creek, Georgia (27.8 mi)
· Sponsor: Emory University
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Teak Research Consults — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Eli Lilly and Company
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
Hypoparathyroidism
Phase 3
Interventional 160 participants sought
MBX Biosciences Investigational Site — Lawrenceville, Georgia (24.8 mi)
· Sponsor: MBX Biosciences
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Treatment Resistant Depression
N/A
Interventional 6,800 participants sought
IACT Health — Grayson, Georgia (28.3 mi)
· Sponsor: LivaNova
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Northside Hospital - Gwinnett — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Emory Johns Creek Hospital — Johns Creek, Georgia (27.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Northeast Georgia Medical Ctr — Gainesville, Georgia (0.6 mi)
· Sponsor: Novo Nordisk A/S
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50566 — Gainesville, Georgia (0.6 mi)
· Sponsor: UCB Biopharma SRL
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Phase 3
Interventional 1,280 participants sought
Northeast Georgia Heart Center, Pc (Nghc) — Gainesville, Georgia (0.6 mi)
· Sponsor: Novo Nordisk A/S
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Emory Johns Creek Hospital — Johns Creek, Georgia (27.8 mi)
· Sponsor: SWOG Cancer Research Network